Concepedia

Ken Duncan

KD

Statistics

Publications

34

Citations

4.6K

H-Index

28

Active since

1995

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Stellenbosch University

London School of Hygiene & Tropical Medicine

University of London

Age UK

Ken Duncan is an author at GlaxoSmithKline (United Kingdom) specializing in life sciences, microbiology, and mycobacterium tuberculosis infection.

Publications per year

1995–2021

34

Publications

34

Evaluation of a nutrient starvation model of <i>Mycobacterium tuberculosis</i> persistence by gene and protein expression profiling

Joanna Betts, Pauline T. Lukey, Linda C. Robb et al. · Molecular Microbiology · 2002 · 1.4K citations · Full text

, , +16

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

Edward A. Weinstein, Takahiro Yano, Linsheng Li et al. · Proceedings of the National Academy of Sciences · 2005 · 294 citations · Full text

, , +14

Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response

Jacqueline M. Cliff, Ji‐Sook Lee, Nicholas Constantinou et al. · The Journal of Infectious Diseases · 2012 · 244 citations

, , +8

Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion

Cherié Butts, Shetha Shukair, Ken Duncan et al. · International Immunology · 2007 · 177 citations · Full text

, , +17

In Situ Detection of <i>Mycobacterium tuberculosis</i> Transcripts in Human Lung Granulomas Reveals Differential Gene Expression in Necrotic Lesions

Gael Fenhalls, Liesel Stevens, Lorraine Moses et al. · Infection and Immunity · 2002 · 163 citations · Full text

, , +12

1–5 of 34